drugset / Trial / NCT06555068
A Trial of HRS-6209 in Combination With Fulvestrant, Letrozole, HRS-8080, or HRS-1358 in Breast Cancer Patients
RandomizedParallel-groupOpen-labelTreatment
Summary
The study is being conducted to evaluate the safety, PK and efficacy of HRS-6209 in Combination with Fulvestrant, Letrozole, HRS-8080, or HRS-1358 for advanced unresectable or metastatic breast cancer
Timeline
- Start
- 2024-08-12
- Primary completion
- 2027-12
- Completion
- 2028-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Fulvestrant | Small molecule | — | — |
| Subject | HRS-1358 | Unknown | — | — |
| Subject | HRS-6209 | Small molecule | — | — |
| Subject | HRS-8080 | Unknown | — | — |
| Subject | HRS-9813 | Unknown | — | — |
| Subject | Letrozole | Other / unclassified | — | — |